Company Search:
Advanced Search
Sponsored Links
Zhenxing Biopharmaceutical & Chemical Inc Company Snapshot
Zhenxing Biopharmaceutical & Chemical Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhenxing Biopharmaceutical & Chemical Inc with three other companies in this sector in China: Walvax Biotechnology Company Limited (2016 sales of 590.16 million Chinese Renmimbi [US$85.70 million] of which 38% was Autonomous Vaccine), Pulike Biological Engineering Inc (583.09 million Chinese Renmimbi [US$84.68 million] of which 93% was Veterinary Chemicals), and Shenzhen Kangtai Biological Products Co Ltd (551.87 million Chinese Renmimbi [US$80.14 million] of which 99% was Biological products).

Sales Analysis. During the year ended December of 2016, sales at Zhenxing Biopharmaceutical & Chemical Inc were 567.44 million Chinese Renmimbi (US$82.40 million). This is an increase of 13.4% versus 2015, when the company's sales were 500.27 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Zhenxing Biopharmaceutical & Chemical Inc (and since 2011, sales have increased a total of 23%). Sales of Pharmaceutical Sales saw an increase of 14.3% in 2016, from 495.41 million Chinese Renmimbi to 566.06 million Chinese Renmimbi. Not all segments of Zhenxing Biopharmaceutical & Chemical Inc experienced an increase in sales in 2016: sales of Other Industry fell 71.8% to 1.37 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhenxing Biopharmaceutical & Chemical Inc
  Stock Performance Chart for Zhenxing Biopharmaceutical & Chemical Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 28.13
(Figures in Chinese Renmimbi)
1 Week 3.2%   13 Weeks -10.6%  
4 Weeks -11.5%   52 Weeks -1.1%  
Zhenxing Biopharmaceutical & Chemical Inc Key Data:
  Ticker: 000403 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 567,436,435
(Year Ending Jan 2017).
Employees: 651
  Currency: Chinese Renmimbi Market Cap: 7,667,607,860
  Fiscal Yr Ends: December Shares Outstanding: 272,577,599
  Share Type: A Gu Closely Held Shares: 72,511,064
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.